POXEL SA (Euronext - POXEL - FR0012432516), a clinical-stage biopharmaceutical company focused on the development of novel treatments for type 2 diabetes and metabolic disease, today announced that...
3775 rue University, Montreal, QC, H3A 2B4, CA/channelsCategory: Medicine and Health Sciences
Dept. of Microbiology and Immunology
Microbiology and Immunology Graduate Seminar
Faculty of Science